F/M Investments’s NeoGenomics NEO Stock Holding History

F/M Investments’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$635K	Buy	43,554 +483	+1%	+$4.66K	0.03%	234
2026 Q1	$320K	Sell	43,071 -1,848	-4%	-$19.4K	0.02%	281
2025 Q4	$528K	Buy	+44,919	New	+$485K	0.02%	329
2025 Q2	–	Sell	-108,773	Closed	-$1.03M	–	416
2025 Q1	$1.03M	Sell	108,773 -17,722	-14%	-$221K	0.04%	286
2024 Q4	$2.08M	Buy	+126,495	New	+$1.96M	0.08%	225

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

F/M Investments's NEO Position: Q2 2026 in Review

F/M Investments increased its NeoGenomics (NEO) stake by 1.1% in Q2 2026, buying an estimated $4.66K and bringing the position to 43,554 shares worth $635K. The position accounts for 0.03% of the portfolio, ranked #234.

F/M Investments first reported a position in NEO in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.08M in Q4 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

F/M Investments held 43,554 shares of NeoGenomics worth $635K as of Q2 2026.
F/M Investments bought 483 NeoGenomics shares in Q2 2026, an estimated $4.66K.
NeoGenomics made up 0.03% of F/M Investments's portfolio in Q2 2026, its #234 holding.
F/M Investments first reported a position in NeoGenomics in Q4 2024 and has held it in 5 quarters since.
F/M Investments's NeoGenomics position peaked at $2.08M in Q4 2024.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.